Anagenex, which combines AI and large-scale proprietary datasets for drug discovery, has raised a $30M Series A led by Catalio Capital Management (Arundhati Parmar/MedCity News)

[ad_1]

Arundhati Parmar / MedCity News:

Anagenex, which combines AI and large-scale proprietary datasets for drug discovery, has raised a $30M Series A led by Catalio Capital Management  —  The CEO of Anagenex believes that the company’s AI engine trained on billions of data points and iterative testing will blow other AI drug discovery startups out of the water.